Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024
Compare Balance Sheet Results of Krebs Biochem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
21.56
7.53
14.03
186.32%
Share Warrants & Outstandings
Total Reserve
-167.80
35.82
-203.62
-568.45%
Shareholder's Funds
-146.24
43.35
-189.59
-437.35%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
161.25
23.90
137.35
574.69%
Secured Loans
0.00
12.13
-12.13
-100.00%
Unsecured Loans
161.25
11.77
149.48
1,270.01%
Deferred Tax Assets / Liabilities
0.00
1.92
-1.92
-100.00%
Other Long Term Liabilities
45.00
0.00
45.00
0.00%
Long Term Trade Payables
2.44
0.00
2.44
0.00%
Long Term Provisions
3.06
0.83
2.23
268.67%
Total Non-Current Liabilities
211.75
26.64
185.11
694.86%
Current Liabilities
Trade Payables
18.15
28.71
-10.56
-36.78%
Other Current Liabilities
33.63
6.65
26.98
405.71%
Short Term Borrowings
50.96
37.73
13.23
35.06%
Short Term Provisions
0.79
0.00
0.79
0.00%
Total Current Liabilities
103.53
73.09
30.44
41.65%
Total Liabilities
169.04
143.08
25.96
18.14%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
314.11
49.43
264.68
535.46%
Less: Accumulated Depreciation
168.40
16.82
151.58
901.19%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
145.70
32.61
113.09
346.80%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.24
29.95
-28.71
-95.86%
Intangible assets under development
1.85
0.00
1.85
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
9.98
1.65
8.33
504.85%
Other Non Current Assets
0.00
0.11
-0.11
-100.00%
Total Non-Current Assets
158.78
64.31
94.47
146.90%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.03
27.94
-21.91
-78.42%
Sundry Debtors
0.05
42.32
-42.27
-99.88%
Cash and Bank
0.14
2.37
-2.23
-94.09%
Other Current Assets
0.47
1.74
-1.27
-72.99%
Short Term Loans and Advances
3.56
4.39
-0.83
-18.91%
Total Current Assets
10.26
78.76
-68.50
-86.97%
Net Current Assets (Including Current Investments)
-93.27
5.67
-98.94
-1,744.97%
Total Current Assets Excluding Current Investments
10.26
78.76
-68.50
-86.97%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
169.04
143.08
25.96
18.14%
Contingent Liabilities
8.47
0.50
7.97
1,594.00%
Total Debt
212.21
61.63
150.58
244.33%
Book Value per share (adjusted)
-67.83
57.56
-125.39
-217.84%
Annual - Borrowings
Borrowings 212.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 45.00 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 146.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024






